Devyser Diagnostics Ab Stock Beta
| DVYSR Stock | 124.50 4.50 3.49% |
Devyser Diagnostics AB fundamentals help investors to digest information that contributes to Devyser Diagnostics' financial success or failures. It also enables traders to predict the movement of Devyser Stock. The fundamental analysis module provides a way to measure Devyser Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Devyser Diagnostics stock.
Devyser |
Devyser Diagnostics AB Company Beta Analysis
Devyser Diagnostics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Devyser Diagnostics AB has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Diagnostics & Research industry. The beta for all Sweden stocks is 100.0% lower than that of the firm.
Devyser Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Devyser Diagnostics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Devyser Diagnostics could also be used in its relative valuation, which is a method of valuing Devyser Diagnostics by comparing valuation metrics of similar companies.Devyser Diagnostics is currently under evaluation in beta category among its peers.
Devyser Fundamentals
| Profit Margin | (0.34) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 762.25 M | |||
| Shares Outstanding | 16.01 M | |||
| Shares Owned By Insiders | 68.12 % | |||
| Shares Owned By Institutions | 34.01 % | |||
| Price To Book | 2.55 X | |||
| Price To Sales | 9.76 X | |||
| Revenue | 116.88 M | |||
| Gross Profit | 71.9 M | |||
| EBITDA | (39.73 M) | |||
| Book Value Per Share | 27.66 X | |||
| Earnings Per Share | (2.11) X | |||
| Target Price | 117.5 | |||
| Number Of Employees | 87 | |||
| Market Capitalization | 1.17 B |
About Devyser Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Devyser Diagnostics AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Devyser Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Devyser Diagnostics AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Devyser Stock Analysis
When running Devyser Diagnostics' price analysis, check to measure Devyser Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devyser Diagnostics is operating at the current time. Most of Devyser Diagnostics' value examination focuses on studying past and present price action to predict the probability of Devyser Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devyser Diagnostics' price. Additionally, you may evaluate how the addition of Devyser Diagnostics to your portfolios can decrease your overall portfolio volatility.